In total, 258 patients with IDH-mutant astrocytomas (114 CNS WHO grade 2, 73 CNS WHO grade 3, 71 CNS WHO grade 4) were studied. The gene discussed is IDH2; the disease is astrocytoma (excluding glioblastoma).